Literature DB >> 28441062

Measles cases among adolescents in southern Pakistan 2012-2015: The case for revisiting vaccination strategies.

Sadia Shakoor1, Erum Khan1, Muhammad Imran Rajput2, Wali Muhammad Rahimoon3.   

Abstract

AIMS: Surveillance of adult measles in Pakistan is a challenge as it does not enjoy the status of a reportable disease unlike childhood cases and therefore cases remain undetected and unreported or misdiagnosed. Consequently no data or estimates of young adult cases, seroprevalence, or estimates of susceptible preadolescent or young adult population exist. We have presented both laboratory conformed and clinically suspected cases of measles occurring in adolescents and adults in the southern province of Sindh in Pakistan.
METHODS: Through an examination of 2 independent databases, i.e. a laboratory database of measles IgM positive cases and clinically detected cases on surveillance performed by the Disease Early Warning System, we have analyzed and reported age-specific positivity rates from 2012 to 2015 in Sindh, Pakistan.
RESULTS: High rates of laboratory confirmed measles were observed in those aged 9 y and younger. Among adolescents and adults, significantly higher positivity rates were observed among those aged 10-19 y. Clinically detected cases from Sindh showed similar distribution of cases.
CONCLUSIONS: High burden of cases among children <9 y of age confirm that supplementary immunization activities (SIAs) among this age group are inadequate and need to be strengthened. Cases among those 10-19 y further demonstrate the need for consolidating SIAs with an additional strategy to vaccinate those who remain non-immune at college entry and in institutions where outbreaks can be prevented. Such measures are essential to achieving the goal of measles elimination in the country and region.

Entities:  

Keywords:  Pakistan; adolescents; adults; measles

Mesh:

Substances:

Year:  2017        PMID: 28441062      PMCID: PMC5512792          DOI: 10.1080/21645515.2017.1311432

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  7 in total

Review 1.  Health seeking behaviour and health services utilization trends in national health survey of Pakistan: what needs to be done?

Authors:  Babar T Shaikh; Juanita Hatcher
Journal:  J Pak Med Assoc       Date:  2007-08       Impact factor: 0.781

Review 2.  A review of EPI progress in Pakistan towards achieving coverage targets: present situation and the way forward.

Authors:  Q Hasan; A H Bosan; K M Bile
Journal:  East Mediterr Health J       Date:  2010       Impact factor: 1.628

3.  Measles susceptibility in children in Karachi, Pakistan.

Authors:  Sana Sheikh; Asad Ali; Anita K M Zaidi; Ajmal Agha; Asif Khowaja; Salim Allana; Shahida Qureshi; Iqbal Azam
Journal:  Vaccine       Date:  2011-03-09       Impact factor: 3.641

4.  The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Amabelia Rodrigues; Christine S Benn; Hilton Whittle
Journal:  BMJ Open       Date:  2012-07-19       Impact factor: 2.692

5.  Socio-psychological factors driving adult vaccination: a qualitative study.

Authors:  Ana Wheelock; Anam Parand; Bruno Rigole; Angus Thomson; Marisa Miraldo; Charles Vincent; Nick Sevdalis
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

6.  Modeling the Impact of Alternative Immunization Strategies: Using Matrices as Memory Lanes.

Authors:  Wladimir J Alonso; Maia A Rabaa; Ricardo Giglio; Mark A Miller; Cynthia Schuck-Paim
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

7.  Progress toward measles elimination--Eastern Mediterranean Region, 2008-2012.

Authors:  Nadia Teleb; Emmaculate Lebo; Hinda Ahmed; Abdel Rahman Hossam; El Tayeb El Sayed; Alya Dabbagh; Peter Strebel; Paul Rota; James Alexander
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-06-13       Impact factor: 17.586

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.